摘要
血小板微颗粒(PMP)是血小板在不同刺激作用下细胞膜脱落所形成的直径小于1.0μm的微粒。循环中PMP水平的增高反映血小板的活化并与血栓相关并发症直接相关。急性冠脉综合征的发生与血小板活化、PMP的释放关系密切。流式细胞仪是PMP定量检测的最常用方法并逐渐得到优化。
出处
《国际心血管病杂志》
2013年第3期132-135,共4页
International Journal of Cardiovascular Disease
参考文献27
-
1Breitenstein A,Tanner FC, Luscher TF. Tissue factor andcardiovascular disease: quo vadis. [J]. Circ J,2010,74(1):3-12.
-
2Biasucci LM, Porto I,Di Vito L,et al. Differences in microparticlerelease in patients with acute coronary syndrome and stableangina[J]. Circ J, 2012,76(9):2174-2182.
-
3Connor DE,Exner T,Ma DD,et al. The majority of circulatingplatelet-derived microparticles fail to bind annexin V,lackphospholipid-dependent procoagulant activity anddemonstrate greater expression of glycoprotein lb [J].Thromb Haemost, 2010,103(5) : 1044-1052.
-
4Schoenwaelder SM, Yuan Y, Josefsson EC, et al. Two distinctpathways regulate platelet phosphatidylserine exposure andprocoagulant function[J]. Blood,2009,114(3) :663-666.
-
5Morel O, Jesel L,Freyssinet JM, et al. Cellular mechanismsunderlying the formation of circulating microparticles [J].Arterioscler Thromb Vase Biol,2011,31 (1) : 15-26.
-
6Aatonen M,Gronholm M, Siljander PR. Platelet-derivedmicrovesicles . multitalented participants in intercellularcommunication[J]. Semin Thromb Hemost, 2012,38(1 ):102-113.
-
7Dale GL,Remenyi G,Friese P. Tetraspanin CD9 is requiredfor microparticle release from coated-platelets[J]. Platelets,2009,20C6):361-366.
-
8Ozaki Y, Suzuki-Inoue K,Inoue O. Novel interactions inplatelet biology: CLEC-2/podoplanin and laminin/GPVl[J].J Thromb Haemost, 2009,7 (Suppl 1) : 191-194.
-
9Mebazaa A. Are platelets a "forgotten^ source of sepsis-inducedmyocardial depressing factor (s). [ J]. Crit Care, 2008,12(1): 110.
-
10Morel O,Toti F,Jesel L, et al. Mechanisms of microparticlegeneration: on the trail of the mitochondrion! [J]. SeminThromb Hemost, 2010,36(8) :833-844.
同被引文献41
-
1杨婉花,石斌,刘长芳,叶冬英,张宏泽,刘鸿翔,欧阳平.血小板微粒对急性冠脉综合征患者危险程度及对疾病预后的预测作用[J].中国老年学杂志,2014,34(1):58-60. 被引量:1
-
2邓新立,傅淑红,李绵洋,丛玉隆.心肌梗死患者和高血压患者血小板微粒CD62P、活化GPⅡb/Ⅲa检测[J].解放军医学杂志,2005,30(7):611-612. 被引量:5
-
3赵燕,沈潞华,杨明,王青,孙一光,孙小勤,陈立伟,马杰.氯吡格雷、阿司匹林对高血压患者血小板微粒CD_(62)p、GPⅡb/Ⅲa的影响[J].临床内科杂志,2007,24(8):544-545. 被引量:2
-
4A. Soop,L. H?llstr?m,C. Frostell,H. Wallén,F. Mobarrez,D. S. Pisetsky.Effect of Lipopolysaccharide Administration on the Number, Phenotype and Content of Nuclear Molecules in Blood Microparticles of Normal Human Subjects[J]. Scand J Immunol . 2013 (2)
-
5Silvia Montoro-Garcia,Esteban Orenes-Pinero,Francisco Marin,Mariano,Valdes,Gregory YH Lip,Eduard Shantsila.Pharmacological Modulation of Microparticle Release: New Strategies for the Management of Atherothrombotic Vascular Disorders[J]. Current Pharmaceutical Design . 2012 (6)
-
6Seongcheol Kim,Maira Carrillo,Uvaraj P. Radhakrishnan,Pudur Jagadeeswaran.Role of zebrafish thrombocyte and non-thrombocyte microparticles in hemostasis[J]. Blood Cells, Molecules and Diseases . 2012 (3)
-
7Pieter H. Reitsma,Henri H. Versteeg,Saskia Middeldorp.Mechanistic View of Risk Factors for Venous Thromboembolism[J]. Arteriosclerosis, Thrombosis, and Vascular Biology . 2012 (3)
-
8Ana A. Weil,Elinor L. Baron,Catherine M. Brown,Mark S. Drapkin.Clinical Findings and Diagnosis in Human Granulocytic Anaplasmosis: A Case Series From Massachusetts[J]. Mayo Clinic Proceedings . 2012 (3)
-
9Philipp Diehl,Alba Fricke,Laura Sander,Johannes Stamm,Nicole Bassler,Nay Htun,Mark Ziemann,Thomas Helbing,Assam El-Osta,Jeremy B.M. Jowett,Karlheinz Peter.Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovascular Research . 2012
-
10Chiara Tamburrelli,Francesco Gianfagna,Marco D’Imperio.Postprandial cell inflammatory response to a standardised fatty meal in subjects at different degree of cardiovascular risk. Thrombosis and Haemostasis . 2012
引证文献3
-
1杨婉花,石斌,刘长芳,叶冬英,张宏泽,刘鸿翔,欧阳平.血小板微粒对急性冠脉综合征患者危险程度及对疾病预后的预测作用[J].中国老年学杂志,2014,34(1):58-60. 被引量:1
-
2梁鹏,周新华,陈开祥.血小板微粒在心血管疾病中的研究进展[J].医学综述,2015,21(13):2340-2343. 被引量:3
-
3马牧欣,符国平,朱勇德,王真奎,赵继义.血小板微粒与急性冠脉综合征危险分层及临床预后的关系[J].内科急危重症杂志,2019,25(5):391-393. 被引量:2
二级引证文献6
-
1杨正亮,金红,李琪,陈宏娟,闫海润.血小板微粒在血栓性疾病中的诊断价值[J].国际检验医学杂志,2016,37(16):2292-2294. 被引量:6
-
2马牧欣,符国平,朱勇德,王真奎,赵继义.血小板微粒与急性冠脉综合征危险分层及临床预后的关系[J].内科急危重症杂志,2019,25(5):391-393. 被引量:2
-
3程庆荣,李结华.红细胞微粒水平与AMI冠状动脉血管病变程度的相关性[J].中南医学科学杂志,2020,48(4):364-367. 被引量:3
-
4徐美辰,曲慧玲.血小板微粒水平与急性脑梗死临床相关性研究[J].中国急救复苏与灾害医学杂志,2021,16(2):136-138. 被引量:2
-
5卢家忠,戎成振.小分子GPⅡb/Ⅲa受体拮抗剂联合经皮冠状动脉介入术可改善急性冠脉综合征患者临床疗效[J].内科急危重症杂志,2021,27(6):501-504. 被引量:2
-
6陈红光,林华颖,于泳浩.微粒与脓毒症相关凝血功能障碍的研究进展[J].中国中西医结合急救杂志,2022,29(3):382-384. 被引量:3
-
1柳桂萍,张育.血小板微颗粒的生物学功能及其与相关临床疾病的关系[J].中华临床医师杂志(电子版),2016,10(2):243-247. 被引量:4
-
2张显飞,郭丹杰.影响血小板微颗粒水平的药物[J].中华医学信息导报,2014,0(8):15-15.
-
3王鸿利.血栓与止血检验进展[J].临床内科杂志,2004,21(1):57-60. 被引量:5
-
4刘嵘,魏文宁,董继华,杨锐,吴健民.血小板微颗粒对人脐静脉内皮细胞组织因子表达影响的初步探讨[J].检验医学,2007,22(4):472-475. 被引量:3
-
5王传新,卢振铎,邓小梅,杨晓静,韩恩吉,徐广润.血小板微颗粒、血小板膜活化糖蛋白在血栓性脑血管疾病诊断与治疗中的意义[J].山东大学学报(医学版),2004,42(2):169-171. 被引量:2
-
6彭黎明,刘芳.血小板微颗粒检测及其临床应用[J].临床检验杂志,2004,22(2):152-154. 被引量:7
-
7沈文红,赵小娟,李慧娟,沈文香,杨海燕,苏雁华,白霞,余自强,阮长耿.成人血小板微颗粒绝对计数方法的建立[J].苏州大学学报(医学版),2010,30(2):313-315.
-
8熊丽丽,魏文宁.血小板微颗粒的检测方法学研究及其临床意义[J].血栓与止血学,2005,11(2):88-90. 被引量:3
-
9卢国元,张淑华,乔青,沈蕾,李明,徐德宇,赵小娟,沈文红,王兆钺.慢性肾病患者血浆血小板微颗粒、内皮细胞微颗粒水平的变化及其意义[J].中华血液学杂志,2010,31(9):626-628. 被引量:1
-
10王鸿利.血栓与止血检测进展[J].微循环学杂志,2007,17(1):4-7. 被引量:2